As AI continues to revolutionise healthcare, critical questions remain about its global impact, accessibility, and long-term market sustainability. Despite rapid advancements, no AI-discovered drug has yet passed Phase 3 clinical trials—how close are we to this breakthrough, and what challenges must be overcome?This closing panel brings together leading experts to explore the future of AI-driven therapeutics, the evolving biotech-pharma relationship, and strategies for ensuring equitable access to AI-powered healthcare innovations.
Key topics include:
• The Road to AI Drug Approval: What hurdles remain before AI-discovered drugs reach the market?
• Funding & Investment: How can we secure sustainable funding for AI-driven drug development?
• Bridging the Accessibility Gap: Ensuring AI-powered healthcare benefits reach global populations
Check out the incredible speaker line-up to see who will be joining Divya.
Download The Latest Agenda